Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Diabetes Service, Endocrinology Unit, IRCCS "Cà Granda - Ospedale Maggiore Policlinico" Foundation, Milan, Italy.
BMJ Open Diabetes Res Care. 2020 Jul;8(1). doi: 10.1136/bmjdrc-2020-001481.
In addition to favoring renal disease progression, renal 'hyperfiltration' has been associated with an increased risk of death, though it is unclear whether and how excess mortality is related to increased renal function. We investigated whether renal hyperfiltration is an independent predictor of death in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events Italian multicenter study.
This observational, prospective cohort study enrolled 15 773 patients with type 2 diabetes consecutively attending 19 Italian diabetes clinics in 2006-2008. Serum creatinine, albuminuria, cardiovascular risk factors, and complications/comorbidities were assessed at baseline. Vital status on 31 October 2015 was retrieved for 15 656 patients (99.26%). Patients were stratified (A) by absolute estimated glomerular filtration rate (eGFR) values in eGFR deciles or Kidney Disease: Improving Global Outcomes (KDIGO) categories and (B) based on age-corrected thresholds or age and gender-specific 95th and 5th percentiles in hyperfiltration, hypofiltration, and normofiltration groups.
The highest eGFR decile/category and the hyperfiltration group included (partly) different individuals with similar clinical features. Age and gender-adjusted death rates were significantly higher in deciles 1, 9, and 10 (≥103.9, 50.9-62.7, and <50.9 mL/min/1.73 m, respectively) versus the reference decile 3 (92.9-97.5 mL/min/1.73 m). Mortality risk, adjusted for multiple confounders, was also increased in deciles 1 (HR 1.461 (95% CI 1.175 to 1.818), p=0.001), 9 (1.312 (95% CI 1.107 to 1.555), p=0.002), and 10 (1.976 (95% CI 1.673 to 2.333), p<0.0001) versus decile 3. Similar results were obtained by stratifying patients by KDIGO categories. Death rates and adjusted mortality risks were significantly higher in hyperfiltering and particularly hypofiltering versus normofiltering individuals.
In type 2 diabetes, both high-normal eGFR and hyperfiltration are associated with an increased risk of death from any cause, independent of confounders that may directly impact on mortality and/or affect GFR estimation. Further studies are required to clarify the nature of this relationship.
NCT00715481.
除了有利于肾脏疾病进展外,肾脏“高滤过”还与死亡风险增加有关,尽管尚不清楚过量死亡率与肾功能增加之间的关系以及如何相关。我们研究了 2006-2008 年间意大利 19 家糖尿病诊所连续就诊的 15773 例 2 型糖尿病患者中,肾脏高滤过是否是死亡的独立预测因子。
这是一项观察性、前瞻性队列研究,纳入了 15773 例连续就诊的 2 型糖尿病患者。基线时评估血清肌酐、白蛋白尿、心血管危险因素和并发症/合并症。2015 年 10 月 31 日检索到 15656 例患者(99.26%)的存活状态。患者根据绝对估计肾小球滤过率(eGFR)在 eGFR 十分位数或肾脏病:改善全球预后(KDIGO)类别中的值进行分层(A),或根据年龄校正的阈值或年龄和性别特异性 95%和 5%百分位值在高滤过、低滤过和正常滤过组中进行分层(B)。
最高的 eGFR 十分位数/类别和高滤过组包括(部分)具有相似临床特征的不同个体。第 1、9 和 10 十分位数(≥103.9、50.9-62.7 和 <50.9 mL/min/1.73 m)与参考十分位数 3(92.9-97.5 mL/min/1.73 m)相比,年龄和性别调整后的死亡率显著更高。调整了多种混杂因素后,第 1 十分位数(HR 1.461(95% CI 1.175-1.818),p=0.001)、第 9 十分位数(1.312(95% CI 1.107-1.555),p=0.002)和第 10 十分位数(1.976(95% CI 1.673-2.333),p<0.0001)的死亡率风险也高于第 3 十分位数。按 KDIGO 类别对患者进行分层也得到了类似的结果。与正常滤过者相比,高滤过者和特别低滤过者的死亡率和调整后的死亡率风险显著更高。
在 2 型糖尿病中,高正常 eGFR 和高滤过均与任何原因导致的死亡风险增加相关,这种相关性不受可能直接影响死亡率和/或影响 GFR 估计的混杂因素的影响。需要进一步研究来阐明这种关系的性质。
NCT00715481。